[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 2746096, "exercisedValue": 0, "unexercisedValue": 2051778}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 2470993, "exercisedValue": 0, "unexercisedValue": 718122}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 35, "title": "Chief Business Officer & Secretary", "yearBorn": 1989, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 11.92, "open": 11.91, "dayLow": 11.745, "dayHigh": 12.2, "regularMarketPreviousClose": 11.92, "regularMarketOpen": 11.91, "regularMarketDayLow": 11.745, "regularMarketDayHigh": 12.2, "beta": 1.246, "forwardPE": -34.672745, "volume": 1058594, "regularMarketVolume": 1058594, "averageVolume": 1251691, "averageVolume10days": 1268930, "averageDailyVolume10Day": 1268930, "bid": 11.99, "ask": 12.07, "bidSize": 500, "askSize": 300, "marketCap": 1168169856, "fiftyTwoWeekLow": 6.7, "fiftyTwoWeekHigh": 18.51, "priceToSalesTrailing12Months": 454.8948, "fiftyDayAverage": 12.3347, "twoHundredDayAverage": 11.989875, "currency": "USD", "enterpriseValue": 963455424, "floatShares": 46520743, "sharesOutstanding": 97185504, "sharesShort": 14670470, "sharesShortPriorMonth": 13675218, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.15100001, "heldPercentInsiders": 0.23834999, "heldPercentInstitutions": 0.7542, "shortRatio": 10.59, "shortPercentOfFloat": 0.2838, "impliedSharesOutstanding": 97185504, "bookValue": 2.069, "priceToBook": 5.80957, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -49104000, "trailingEps": -0.5, "forwardEps": -0.76, "enterpriseToRevenue": 375.177, "enterpriseToEbitda": -15.94, "52WeekChange": 0.5851064, "SandP52WeekChange": 0.22903383, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "SPRY", "underlyingSymbol": "SPRY", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1607092200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d8a743bf-b873-3187-ac17-afe99130ffb3", "messageBoardId": "finmb_585213447", "gmtOffSetMilliseconds": -18000000, "currentPrice": 12.02, "targetHighPrice": 40.0, "targetLowPrice": 19.0, "targetMeanPrice": 29.8, "targetMedianPrice": 28.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 204816000, "totalCashPerShare": 2.107, "ebitda": -60444000, "totalDebt": 102000, "quickRatio": 12.396, "currentRatio": 12.56, "totalRevenue": 2568000, "debtToEquity": 0.051, "revenuePerShare": 0.027, "returnOnAssets": -0.16225, "returnOnEquity": -0.22409001, "grossProfits": -17301000, "freeCashflow": -21208250, "operatingCashflow": -45861000, "operatingMargins": -10.51644, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]